University Hospitals Brain Health & Memory Center is now treating patients with KISUNLA™ (donanemab), a Food and Drug ...

A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...

Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.

The FDA has fast-tracked a drug to treat severe traumatic brain injury from Swedish pharma ... in order to get the product approved and to patients faster. NeuroSTAT works by protecting and ...

In today’s fast-paced world, maintaining optimal cognitive function is essential. Many people struggle with brain fog, ...

a sleeping drug that had been proven to increase NREM sleep time. In theory, zolpidem should have boosted brain-clearing. But it turned it off instead. “When we looked at the mice after giving ...

Kebilidi is the first gene therapy approved by the FDA for administration directly into the brain, given via a cannula during a surgical procedure, and replaces the human dopa decarboxylase (DDC ...

This has demonstrated the potential of palbociclib in treating Alzheimer’s disease,” Chen said. The research shows the drug ...

The U.S. Food and Drug Administration (FDA) has granted approval to crinecerfont ... this drug targets a specific protein in the brain known as the CRF1 receptor, located in the pituitary gland.

A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.

People often look for methods to boost memory due to its importance in our daily activities. One such approach includes the use of supplements designed to increase brain function. These ...